⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL523804 | 1.00 | — | — | |
| SCHEMBL3954454 | 1.00 | — | — | |
| Hexane SCHEMBL17769241 | 0.90 | PTPN1 (0.43) | — | |
| SCHEMBL19630059 | 0.83 | — | — | |
| SCHEMBL26516294 | 0.83 | — | — | |
| SCHEMBL14174319 | 0.83 | — | — | |
| SCHEMBL12564801 | 0.81 | ALDH1A1 (0.50) | — | |
| SCHEMBL4578719 | 0.79 | — | — | |
| SCHEMBL87711 | 0.77 | — | — | |
| SCHEMBL523957 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 481 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116283925-B | Iminophenazine derivative coupling molecule for treating bacterial infection and application thereof | 丹诺医药(苏州）有限公司 | 2025-05-20 | — | — | CN | claimed |
| EP-4514796-A1 | CDK INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | OnQuality Pharmaceuticals China Ltd. (CN) | 2025-03-05 | — | — | EP | claimed |
| US-12173020-B2 | New-type oxazolidinone compounds and preparation method therefor | HC Synthetic Pharmaceutical Co., Ltd. (CN) | 2024-12-24 | — | — | US | claimed |
| CN-118702642-A | Method for synthesizing 5-hydroxymethyl oxazolidinone | 南京工业大学 | 2024-09-27 | — | — | CN | claimed |
| CN-118702641-A | Method for synthesizing 5-hydroxymethyl oxazolidinone by catalyzing epoxy amine and carbon dioxide | 南京工业大学 | 2024-09-27 | — | — | CN | claimed |
| CN-118201916-A | Piperazinylsulfonylaryl compounds for the treatment of bacterial infections | 豪夫迈·罗氏有限公司 | 2024-06-14 | — | — | CN | claimed |
| WO-2023207875-A1 | CDK INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | ONQUALITY PHARMACEUTICALS CHINA LTD. (CN) | 2023-11-02 | — | — | WO | claimed |
| CN-116730938-A | Method for synthesizing 5-hydroxymethyl oxazolidinone | 南京工业大学 | 2023-09-12 | — | — | CN | claimed |
| CN-116283925-A | Iminophenazine derivative coupling molecule for treating bacterial infection and application thereof | 丹诺医药(苏州）有限公司 | 2023-06-23 | — | — | CN | claimed |
| US-20230046407-A1 | NEW-TYPE OXAZOLIDINONE COMPOUNDS AND PREPARATION METHOD THEREFOR | HC Synthetic Pharmaceutical Co., Ltd. (CN) | 2023-02-16 | — | — | US | claimed |
| WO-2003027083-A1 | BICYCLO[3,1,0]HEXANE CONTAINING OXAZOLIDINONE ANTIBIOTIC AND DERIVATIVES THEREOF | MERCK & CO., INC. (US) | 2003-04-03 | — | — | WO | claimed |
| WO-2002024669-A1 | PROCESS FOR THE PREPARATION OF 5-HYDROXYMETHYL 2-OXAZOLIDINONE AND NOVEL INTERMEDIATE | MICHIGAN STATE UNIVERSITY (US) | 2002-03-28 | — | — | WO | claimed |
| US-6288238-B1 | REACTION OF 3,4-CYCLIC BORONIC ACID ESTER AND 3,4-DIHYDROXY BUTYRAMIDE WITH ALKALI OR ALKALINE EARTH METAL HYPOHALITE OR HYDROXIDE TO PRODUCE 5-HYDROXYMETHYL-2-OXAZOLIDINONE | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY | 2001-09-11 | — | — | US | claimed |
| EP-0835254-B1 | OXAZOLIDINONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTICAL USE | SYNTHELABO (FR) | 1999-09-01 | — | — | EP | claimed |
| US-5843975-A | Oxazolidinone derivatives, their preparation and therapeutical use | SYNTHELABO (FR) | 1998-12-01 | — | — | US | claimed |
| EP-0835254-A1 | OXAZOLIDINONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTICAL USE | SYNTHELABO (FR) | 1998-04-15 | — | — | EP | claimed |
| WO-1996038444-A1 | OXAZOLIDINONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTICAL USE | SYNTHELABO (FR) | 1996-12-05 | — | — | WO | claimed |
| EP-0175363-B1 | 4,5-DIHYDRO-3(2H)-PYRIDAZINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE | CASSELLA Aktiengesellschaft (DE) | 1990-01-17 | — | — | EP | claimed |
| US-4816454-A | CARDIOVASCULAR DISORDERS | CASSELLA AKTIENGESELLSCHAFT (DE) | 1989-03-28 | — | — | US | claimed |
| EP-0175363-A2 | 4,5-Dihydro-3(2H)-pyridazinones, process for their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1986-03-26 | — | — | EP | claimed |